How To Treat Diabetes
|
|
- Clara Nicholson
- 3 years ago
- Views:
Transcription
1 Overview of Diabetes Medications Marie Frazzitta DNP, FNP c, CDE, MBA Senior Director of Disease Management North Shore LIJ Health Systems Normal Glucose Metabolism Insulin is produced by beta cells in the pancreas Insulin binds to its receptor on the target cell to allow for glucose entry into the cells Glucose Regulation Insulin Hyperglycemia Normal Range Hypoglycemia Glucagon Diabetes Educational Services 1
2 Diabetes is a metabolic disease In which the body can not make insulin Beta Cell Failure Type 1 Diabetes Is unable to utilize the insulin it makes Insulin Resistance Type 2 Diabetes Or both Beta Cell Dysfunction and Insulin Resistance Type 2 Diabetes Diabetes Types Key characteristics of type 1, LADA, and type 2 Type 1 LADA Type 2 Typical age of onset Youth or Adult Adult Youth or Adult Progression to insulin dependence Immediate Latent (months/years) Slow Presence of autoantibodies Yes Yes No Insulin dependence Yes/ at diagnosis Yes Over time, if at all Insulin resistance No Possible Yes Medications Used for Diabetes Medication Class Biguanide Sulfonylurea 2nd Gen Glipizide, Meglinide Thiazolidinedione α glucosidase inhibitor SGLT2 inhibitor DPP 4 Inhibitor GLP 1 agonist Amylin mimetic Insulin Metformin Medications Glyburide, Glimepiride Repaglinide, Nateglinide Pioglitazone, Rosiglitazone Acarbose, Miglitol Canagliflozin, Dapagliflozin, Empagliflozin Sitagliptin, Saxagliptin, Linagliptin, Alogliptin Exenatide, Liraglutide Pramlintide Various 2
3 Biguanide TZD Insulin SU/Meglinides DPP 4 Inhibitor GLP 1 agonist Amylin Mimetic α Glucosidase Inhibitor Biguanide TZD Circulatory System Glucose FFA Kidney TZD Biguanide SGLT inhibitor Promotes Blocks What is an Hemoglobin A1C number? Each % changes approx 30 points Biguanide Medication(s) Metformin (Glucophage ) How does it work? Decreases hepatic glucose production Increases peripheral insulin sensitivity A1C reduction 1 2% Contraindication (CI) Side Effects Comments Serum creatinine (mg/dl)male 1.5 or female 1.4 Acute or chronic acidosis, Hepatic dysfunction Excessive alcohol intake, Type I DM, Diabetic ketoacidosis (DKA) Weight loss, nausea, vomiting, epigastric pain, bloating, gas Max daily dose: 2550mg Start at 500mg daily and titrate up every 1 2 weeks Precaution with iodine containing contrast dye May improves lipid profile (decrease TG, LDL, Total cholesterol and Increase HDL) 3
4 Medication(s) How does it work? Sulfonylurea Glyburide (Diabeta ; Glynase ) Glipizide (Glucotrol ) Glimeperide (Amaryl ) A1C reduction 1 2% Contraindicated Type I DM, DKA Increase the release of insulin from the pancreas Side Effects Comments Hypoglycemia, weight gain All renally cleared Glyburide on Beers Criteria Caution in irregular eating pattern Medication(s) How does it work? A1C reduction % Contraindicated Type I DM, DKA Meglinides Repaglinide (Prandin ), Nateglinide (Starlix ) Increase the release of insulin from the pancreas Side Effects Comments Hypoglycemia, weight gain Take before meals No meal No medication (Repaglinide) caution with renal and hepatic impairment Thiazolidinediones Medication(s) How does it work? Pioglitazone (Actos ), Rosiglitazone (Avandia ) Improves insulin sensitivity Decreasing free fatty acids A1C reduction % Contraindicated Side Effects Comments NYHA Class III/IV heart failure, active liver disease Type I DM, DKA Weight gain, fluid retention, bone fractures, hepatic impairment Takes about 8 12 weeks to achieve maximum effect May improves lipid profile (Increase HDL, Decrease triglyceride) 4
5 Sodium Glucose co Transporter 2 Inhibitor (SGLT2 inhibitor) Medication(s) How does it work? Canagliflozin (Invokana ), Dapagliflozin (Farxiga ), Empagliflozin (Jardiance ) Reduces reabsorption of glucose in the kidney Lowers renal threshold for glucose excretion A1C reduction 0.8 1% Contraindicated Severe renal impairment, dialysis, Type I DM, DKA Side Effects Urinary tract infection, female genital infection Comments All once a day medication Taken with or without food DPP 4 inhibitor and GLP1 agonist Incretin or GLP1 Stimulates insulin release Inhibits glucagon release Goal Lowering Blood Glucose DPP 4 inhibitor Prevents enzymes effect DPP 4 enzyme Breaks down GLP Medication(s) How does it work? Dipeptidyl Peptidase 4 inhibitor (DPP 4 Inhibitors) Sitagliptin (Januvia ), Saxagliptin (Onglyza ), Linagliptin (Tradjenta ) Inhibits breakdown of incretin, glucagon like peptide 1 (GLP 1) Reduces glucagon secretion Slows GET, promotes satiety A1C reduction % Contraindicated Pancreatitis Type I DM DKA Side Effects Hypoglycemia when used with insulin Comments Renally dosed except for linagliptin All once a day medication Taken with or without food 5
6 GLP 1 Agonist (Incretin Mimetic) Medication(s) How does it work? Exenatide (Byetta, Bydureon ), Liraglutide (Victoza ) Increases glucose dependent insulin secretion Reduces glucagon secretion Slows gastric emptying time (GET),promotes satiety A1C reduction % Contraindicated Medullary thyroid carcinoma, multiple endocrine neoplasia syndrome Type 2, Type I DM, DKA Side Effects Hypoglycemia, pancreatitis, acute renal failure, nausea/vomiting/diarrhea, weight loss Comments Only used to treat Type 2 diabetes Available in injectable pen form Should be discarded within 30 days after its use Amylin Mimetic Medication(s) Pramlintide (Symlin ) How does it Reduces glucagon secretion work? Slows gastric emptying time (GET),promotes satiety A1C reduction 0.5 1% Contraindicated Hypoglycemia unawareness, confirmed gastroparesis, DKA Side Effects Hypoglycemia unawareness, headache, nausea, vomiting, weight loss Comments Dose of medication depends on the type of DM Pramlintide alone does not cause hypoglycemia Insulin dose decreased by 50% Taken before meals take contain at least 250calories or 30 gram of carbohydrates Insulin Preparations Insulin preparations Brand name Type Onset of action Peak Duration of action Rapid acting (administer immediately before meal) Humalog Insulin lispro 5 15 min hr 3 5 hr Novolog Insulin aspart 5 15 min hr 3 5 hr Apidra Insulin glulisine 5 15 min hr 3 5 hr Short acting (administer 30 min before meal) Humulin R Novolin R Regular human insulin min 2 3 hr 5 8 hr Intermediate acting Humulin N Novolin N Isophane insulin suspension (NPH) 2 4hr 4 10hr 10 16hr Long acting Lantus Insulin glargine 2 3hr None 20 24hr Levemir Insulin detemir 1 2 hr None Dose dependent ~6 23 hr Premixes Humalog mix 75/25 75% lispro protamine suspension 5 15 min Dual 10 16hr (NPL)/25% lispro Novolog mix 70/30 70% protamine crystalline 5 15 min Dual 10 16hr aspart/30% aspart Humulin 70/30 70% NPH/30% regular min Dual 10 16hr Novolin 70/30 Humalog mix 50/50 50% NPL/50% lispro 5 15 min Dual 10 16hr Concentrated Insulin Humulin U 500 Regular human insulin 500 units/ml 30 min 1 3 hr 8 24 hr 6
7 The Duration of Action of Insulin O:5 15min / D:3 5 hours O:30 60min / D:5 8 hours O:2 4 hours/ D:10 16 hours O:1 2 hours/ D:6 23 hours O:2 3 hours/ D:20 24 hours Legend: O=Onset / D=Duration How do we use different type of insulin? How do we use different type of insulin? 7
8 Mixing Insulin INSULIN TYPE OF INSULIN APPEARANCE Lispro (Humalog ) Clear Aspart (Novolog ) Rapid Clear Glulisine (Apidra ) Clear Regular (Novolin R or Humulin R ) Short Clear NPH (Novolin N or Humulin N ) Intermediate Cloudy FIRST clear-short acting THEN cloudy-longer acting Gently mix cloudy insulin Dosing SQ Insulin TOTAL DAILY TYPE OF PATIENT INSULIN DOSE 0.3 UNITS/KG Lean patients (BMI<18.5 or at high risk of hypoglycemia ) 0.4 UNITS/KG Normal (BMI ) 0.5 UNITS/KG Overweight patients (BMI ) 0.6 UNITS/KG Obese patients (BMI>30) or highly insulin resistant Calculating SQ dose Calculate Total Daily Dose 50% Basal /50% Meals 33%Breakfast / 33%Lunch / 33% Dinner Patient s: BMI 32 / weight 100kg 0.6units/kg x 100kg = 60 units total daily dose Basal dose 60 / 2 = 30 unit Lantus once a day Meal Dose 30/3 = 10units Humolog before each meal Determine how much patient is eating 8
9 Which medications can cause low blood sugar? Insulin Sulfonylurea Meglitinides GLP 1 agonist Amylin mimetic 15:15 Rule Treatment of Blood sugars of <70 START When <70mg/dL Glucagon Allows the breakdown of glycogen into glucose Treatment dose for hypoglycemia >20 kg : 1 mg (1 unit) subcutaneous, IM or IV <20 kg: 0.5 mg (0.5 unit) subcutaneous, IM or IV 9
10 Clinical Use 80yo M with Type 2 Diabetes is required to receive angiogram with contrast. Which medication should be discontinue? A. Glipizide B. Repaglinide C. Metformin D. Acarbose Clinical Use Which diabetes medication can cause weight gain and fluid retention? A. Rosiglitazone B. Repaglinide C. Insulin D. Glipizide Clinical Use 300lb patient is newly diagnosed with Type 2 Diabetes. The patient s hemoglobin A1C is 8%. Which medication is most appropriate for this patient? A. Glipizide B. Insulin C. Metformin D. Rosiglitazone 10
11 Medications that affect weight Decrease Exenatide (Byetta ) Liraglutide (Victoza ) Pramlintide (Symlin ) Metformin (Glucophage ) Increase Sulfonylureas Meglitinides Insulins Thiazolidinediones Clinical Use 90yo M with Type 2 Diabetes was readmitted for a fall at home. On admission the blood sugar was 50mg/dL and later on labs showed his A1C to be 5.5%. Which medication most likely caused his hypoglycemia? A. Glyburide B. Sitagliptin C. Metformin D. Rosiglitazone Which medications can cause low blood sugar? Insulin Sulfonylurea Meglitinides GLP 1 agonist Amylin mimetic 11
12 Clinical Use Which Medicare part covers diabetes medications and diabetes supplies (syringe, needle, alcohol swabs, gauze)? A. Medicare Part A B. Medicare Part B C. Medicare Part C D. Medicare Part D Reference: Medicare coverage for Diabetes at a Glance Clinical Use Which Medicare part covers blood sugar testing equipment and supplies? A. Medicare Part A B. Medicare Part B C. Medicare Part C D. Medicare Part D Reference: Medicare coverage for Diabetes at a Glance Medications that can cause Hyperglycemia Cortiosteroids Atypical antipsychotics (such as Clozapine, Risperidone, Olanzapine, Quetiapine) Niacin Beta blockers Protease inhibitors 12
13 Medication in regards to food With Food Metformin Sulfonylurea Meglitinides Alphaglucosidase inhibitor Amylin mimetics Rapid acting insulin Exenitide Doesn t matter Thiazolidinediones DPP 4 Inhibitor Liraglutide Sandra is a 26 year old woman with type 1 diabetes. She is a school teacher and has a very active social life. Her insulin dosage is 18 units of lantus HS and an Insulin to carbohydrate ratio of 1:10 for breakfast and 1:15 for lunch and dinner. She came in today because for the last week she has been waking up with high fasting levels. She had recently lost about 10 lbs. Fasting After Breakfast Before Lunch After Lunch Before Dinner After Dinner JR has type 2 diabetes. BMI 32. He is currently taking metformin 1000mg QD and Januvia 100mg daily. He is a long distance truck driver and works many hours. He came in today for his regular visit. Fasting After Breakfast Before Lunch After Lunch Before Dinner After Dinner
14 ML has type 2 diabetes. He is on Metformin 2000mgqd and prandin 1mg ac meals. His last HbA1c was 8.6%. Below is his log book and food diary. Dates Fasting After Breakfast Before Lunch After Lunch Before Dinner After Dinner 5/ / / / / Take Home Points Know the medication class characteristics Know the medication class side effects What is best for my patient??? Diabetes care should be individualized Questions? 14
10/30/2012. Anita King, DNP, RN, FNP, CDE, FAADE Clinical Associate Professor University of South Alabama Mobile, Alabama
Faculty Medications for Diabetes Satellite Conference and Live Webcast Wednesday, November 7, 2012 2:00 4:00 p.m. Central Time Anita King, DNP, RN, FNP, CDE, FAADE Clinical Associate Professor University
More informationType 2 Diabetes Medicines: What You Need to Know
Type 2 Diabetes Medicines: What You Need to Know Managing diabetes is complex because many hormones and body processes are at work controlling blood sugar (glucose). Medicines for diabetes include oral
More informationDIABETES EDUCATION. *Read package insert each time you refill your medications in case there is new information SULFONYLUREAS
DIABETES EDUCATION *Read package insert each time you refill your medications in case there is new information SULFONYLUREAS ACTION: Sulfonylureas stimulate the pancreas to make more insulin (pancreas
More informationPharmaceutical Management of Diabetes Mellitus
1 Pharmaceutical Management of Diabetes Mellitus Diabetes Mellitus (cont d) Signs and symptoms 2 Elevated fasting blood glucose (higher than 126 mg/dl) or a hemoglobin A1C (A1C) level greater than or equal
More informationMary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes
Mary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes Objectives Pathophysiology of Diabetes Acute & Chronic Complications Managing acute emergencies Case examples 11/24/2014 UWHealth
More informationFYI: (Acceptable range for blood glucose usually 70-110 mg/dl. know your institutions policy.)
How Insulin Works: Each type of insulin has an onset, a peak, and a duration time. Onset is the length of time before insulin reaches the bloodstream and begins lowering blood Peak is the time during which
More informationComparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians
Clinician Research Summary Diabetes Type 2 Diabetes Comparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians A systematic review of 166 clinical studies published between
More informationDIABETES MEDICATION-ORAL AGENTS AND OTHER HYPOGLYCEMIC AGENTS
Section Two DIABETES MEDICATION-ORAL AGENTS AND OTHER HYPOGLYCEMIC AGENTS This section will: Describe oral agents (pills) are specific for treating type 2 diabetes. Describe other hypoglycemic agents used
More informationMedicines Used to Treat Type 2 Diabetes
Goodman Diabetes Service Medicines Used to Treat Type 2 Diabetes People who have type 2 diabetes may need to take medicine to help lower their blood glucose, in addition to being active & choosing healthy
More informationApproximate Cost Reference List i for Antihyperglycemic Agents
Alpha Glucosidase Inhibitor Acarbose (Glucobay ) Biguanides Metformin (Glucophage, generic) Metformin ER (Glumetza ) Approximate Cost Reference List i for Antihyperglycemic Agents Incretin Agents - DPP-4
More informationAntidiabetic Drugs. Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Antidiabetic Drugs Mosby items and derived items 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Diabetes Mellitus Two types Type 1 Type 2 Type 1 Diabetes Mellitus Lack of insulin production
More informationDiabetes Treatments: Options for Insulin Delivery. Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute
Diabetes Treatments: Options for Insulin Delivery Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute Diabetes 21 million people in the U.S. have diabetes $132 billion each
More informationAdd: 2 nd generation sulfonylurea or glinide or Add DPP-4 inhibitor Start or intensify insulin therapy if HbA1c goals not achieved with the above
Guidelines for Type Diabetes - Diagnosis Fasting Plasma Glucose (confirm results if borderline) HbAIC Normal FPG < 00 < 5.5 Impaired Fasting Glucose (IFG) 00 to < 5.7%-.5% Diabetes Mellitus (or random
More informationDiabetes Mellitus Pharmacology Review
Diabetes Mellitus Pharmacology Review Hien T. Nguyen, Pharm.D., BCPS Clinical Pharmacist Specialist AtlantiCare Regional Medical Center E-Mail: HienT.Nguyen@atlanticare.org Objectives 1. Review the epidemiology
More information25 mg QD-TID @ meals w/1st bite of. food, titrate Q 4 8 weeks; adjust based on 1 postprandial glucose; 100 mg TID max
Table Selected Non-Insulin Antihyperglycemic Agents Class Drug (Brand) Dosing Comments -Glucosidase inhibitors Acarbose a (Precose) 25 mg QD-TID @ meals w/1st bite of MOA: Enzyme inhibitor, delays hydrolysis
More informationDiabetes Medications. Minal Patel, PharmD, BCPS
Diabetes Medications Minal Patel, PharmD, BCPS Objectives Examine advantages and disadvantages of oral anti-hyperglycemic medications Describe the differences between different classes of insulin Explore
More informationFundamentals of Diabetes Care Module 5, Lesson 1
Module 5, Lesson 1 Fundamentals of Diabetes Care Module 5: Taking Medications Healthy Eating Being Active Monitoring Taking Medication Problem Solving Healthy Coping Reducing Risks Foundations For Control
More informationMedicines for Type 2 Diabetes A Review of the Research for Adults
Medicines for Type 2 Diabetes A Review of the Research for Adults Is This Information Right for Me? Yes, if: Your doctor or health care provider has told you that you have type 2 diabetes and have high
More informationNoninsulin Diabetes Medications Summary Chart Medications marked with an asterisk (*) can cause hypoglycemia MED GROUP DESCRIPTOR
Noninsulin Diabetes Medications Summary Chart Medications marked with an asterisk (*) can cause MED GROUP DESCRIPTOR INSULIN SECRETAGOGUES Sulfonylureas* GLYBURIDE* (Diabeta) (Micronase) MICRONIZED GLYBURIDE*
More informationDiabetes Update Lanita S. Shaverd, Pharm.D. Director, UAMS 12 th Street Health and Wellness Center Assistant Professor, UAMS College of Pharmacy
Objectives Review oral medications used for the treatment of diabetes Explain how to effectively combine oral diabetes medications for optimal results Discuss insulins and non-insulin injectable diabetes
More informationDiabetes: Medications
Diabetes: Medications Presented by: APS Healthcare Southwestern PA Health Care Quality Unit (APS HCQU) May 2008 sh Disclaimer Information or education provided by the HCQU is not intended to replace medical
More informationAcarbose INITIAL: 25 mg PO TID ($45) Miglitol INITIAL: 25 mg PO TID ($145)
PL Detail-Document #310601 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER June 2015 Drugs for Type 2
More informationDiabetes Mellitus 1. Chapter 43. Diabetes Mellitus, Self-Assessment Questions
Diabetes Mellitus 1 Chapter 43. Diabetes Mellitus, Self-Assessment Questions 1. A 46-year-old man presents for his annual physical. He states that he has been going to the bathroom more frequently than
More informationINSULIN INTENSIFICATION: Taking Care to the Next Level
INSULIN INTENSIFICATION: Taking Care to the Next Level By J. Robin Conway M.D., Diabetes Clinic, Smiths Falls, ON www.diabetesclinic.ca Type 2 Diabetes is an increasing problem in our society, due largely
More informationMedications for Type 2 Diabetes
Main Page Risk Factors Symptoms Diagnosis Treatment Screening Complications Reducing Your Risk Talking to Your Doctor Living With Type 2 Diabetes Resource Guide Medications for Type 2 Diabetes by Karen
More informationCLASS OBJECTIVES. Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies
Insulins CLASS OBJECTIVES Describe the history of insulin discovery List types of insulin Define indications and dosages Review case studies INVENTION OF INSULIN 1921 The first stills used to make insulin
More informationGuidelines for Type 2 Diabetes Diagnosis
Guidelines for Type 2 Diabetes Diagnosis Fasting Plasma Glucose (in asymptomatic individuals, repeat measurement to confirm the test) Normal FPG < 100 2-hr OGTT < 140 HbA1C < 5.5% Impaired Fasting Glucose
More informationDiabetes Fundamentals
Diabetes Fundamentals Prevalence of Diabetes in the U.S. Undiagnosed 10.7% of all people 20+ 23.1% of all people 60+ (12.2 million) Slide provided by Roche Diagnostics Sources: ADA, WHO statistics Prevalence
More informationAnti-Diabetic Agents. Chapter. Charles Ruchalski, PharmD, BCPS. Drug Class: Biguanides. Introduction. Metformin
Chapter Anti-Diabetic Agents 2 Charles Ruchalski, PharmD, BCPS Drug Class: Biguanides The biguanide metformin is the drug of choice as initial therapy for a newly diagnosed patient with type 2 diabetes
More informationCara Liday, PharmD, CDE Associate Professor, Idaho State University Clinical Pharmacist and CDE, InterMountain Medical Center Pocatello, ID The planners and presenter have disclosed no conflict of interest,
More informationTREATMENT STRATEGIES FOR MANAGING TYPE 2 DIABETES MELLITUS. Friday, August 16, 13
TREATMENT STRATEGIES FOR MANAGING TYPE 2 DIABETES MELLITUS 1 Heather Healy, FNP-BC Martha Shelver, CS, ACNP-BC Saint Alphonsus Regional Medical Center 2 OBJECTIVES 3 Review the current management algorithms
More informationWhat I need to know about. Diabetes Medicines. National Diabetes Information Clearinghouse
What I need to know about Diabetes Medicines National Diabetes Information Clearinghouse What I need to know about Diabetes Medicines Contents What do diabetes medicines do?... 1 What targets are recommended
More informationMaking Clinical Sense of Diabetes Medications. Types of Diabetes. Pathophysiology. Beta Cell Function & Glucagon
Making Clinical Sense of Diabetes Medications Kathy Reily, RD, CDE Prince William Hospital Diabetes Program Coordinator Virginia Dietetic Association April 4, 2011 Types of Diabetes Type 1 DM = Beta Cell
More informationDiabetes Medications at the End of Life. Goals and Objectives. Diabetes. Type 2 Diabetes Mellitus. Types of Diabetes
Diabetes Medications at the End of Life Paul J. Schmidt Jr., R.Ph., M.S. Clinical Supervisor HospiScript Services pschmidt@hospiscript.com Goals and Objectives Describe the Current Impact of Diabetes Mellitus
More informationEndocrine Disorders. Diabetes Meds Objectives. Diabetes Type 1 and Type 2. Insulin Dynamics. Insulin is all about timing! Rapid acting insulin O P D
Endocrine Disorders Diabetes Meds Objectives Explain the action of the various types of insulin currently available Identify the relationship between insulin peak and risk for hypoglycemia Discuss rationale
More informationTargeting the Kidney. Renal Glucose Transport 11/4/2015. Non insulin Agents Available IBITORS. Chao EC, et al. Nat Rev Drug Discovery. 2010;9:551 559.
SGLT-2i and DPP-IVi in the Management of Diabetes Mellitus Type 2 Abel Alfonso, D.O., F.A.C.E. Endocrinologist November 5, 2015 DIABETES: CURRENT RATES AND PROJECTIONS CDC Press Release 2010: 1 in 3 adults
More informationPrimary Care Type 2 Diabetes Update
Primary Care Type 2 Diabetes Update May 16, 2014 Presented by: Barb Risnes APRN, BC-ADM, CDE Objectives: Discuss strategies to address common type 2 diabetes patient management challenges Review new pharmacological
More informationTreatment Approaches to Diabetes
Treatment Approaches to Diabetes Dr. Sarah Swofford, MD, MSPH & Marilee Bomar, GCNS, CDE Quick Overview Lifestyle Oral meds Injectables not insulin Insulin Summary 1 Lifestyle & DM Getting to the point
More informationAntidiabetic Agents. Chapter. Biguanides
ajt/shutterstock, Inc. Chapter 2 Antidiabetic Agents Charles Ruchalski, PharmD, BCPS Biguanides Introduction For newly diagnosed patients with type 2 diabetes, the biguanide metformin is the drug of choice
More informationDiabetes: When To Treat With Insulin and Treatment Goals
Diabetes: When To Treat With Insulin and Treatment Goals Lanita. S. White, Pharm.D. Director, UAMS 12 th Street Health and Wellness Center Assistant Professor of Pharmacy Practice, UAMS College of Pharmacy
More informationType 2 Diabetes Medications: SGLT2 Inhibitors
Type 2 Diabetes Medications: SGLT2 Inhibitors SGLT2 inhibitors are a class of type 2 diabetes medications used along with diet and exercise to lower blood glucose How are they taken? SGLT2 inhibitors is
More informationAntihyperglycemic Agents Comparison Chart
Parameter Metformin Sulfonylureas Meglitinides Glitazones (TZD s) Mechanism of Action Efficacy (A1c Reduction) Hepatic glucose output Peripheral glucose uptake by enhancing insulin action insulin secretion
More informationBritni Hebert, MD PGY-1
Britni Hebert, MD PGY-1 Importance of Diabetes treatment Types of treatment Comparison of treatment/article Review Summary Example cases 1 out of 13 Americans have diabetes Complications include blindness,
More informationSUBJECT: DIABETES MEDICATION MANAGEMENT PROTOCOLS
SUBJECT: DIABETES MEDICATION MANAGEMENT PROTOCOLS PURPOSE To establish a process that will enable Certified Diabetes Educators (CDE) and/or staff with Board Certification in Advanced Diabetes Management
More informationwe have to keep up. Timothy S. Reid, M.D. Mercy Diabetes Center Janesville, WI Entity Activity Financial Consideration Comments
Timothy S. Reid, M.D. Mercy Diabetes Center Janesville, WI Entity Activity Financial Consideration Comments Novo Nordisk Speaker/Consultant Speaker Fees/Honoraria Sanofi-Aventis Speaker/Consultant Speaker
More informationThe prevalence of diabetes in the United States in
Medical Management of Type 2 Diabetes Celia Levesque, CNS-BC ABSTRACT More than 20 million Americans have type 2 diabetes. Managing blood glucose is an important component in delaying, slowing, or preventing
More informationPills for Type 2 Diabetes. A Guide for Adults
Pills for Type 2 Diabetes A Guide for Adults December 2007 Fast Facts on Diabetes Pills n Different kinds of diabetes pills work in different ways to control blood sugar (blood glucose). n All the diabetes
More informationTreatment of Type 2 Diabetes
Improving Patient Care through Evidence Treatment of Type 2 Diabetes This information is based on a comprehensive review of the evidence for best practices in the treatment of type 2 diabetes and is sponsored
More informationLet s Talk About Meters and Meds. Adapted for Upstate Medical University by: Kristi Shaver, BS, RN, CDE, MS-CNS Student (2014) January 2014
Let s Talk About Meters and Meds Adapted for Upstate Medical University by: Kristi Shaver, BS, RN, CDE, MS-CNS Student (2014) January 2014 How to monitor diabetes control: Hemoglobin A 1 C, or just A 1
More informationA Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or
A Simplified Approach to Initiating Insulin When to Start Insulin: 1. Fasting plasma glucose (FPG) levels >250 mg/dl or 2. Glycated hemoglobin (A1C) >10% or 3. Random plasma glucose consistently >300 mg/dl
More informationInsulin therapy in type 2 diabetes When and how? Disclosures. Learning Objectives. None relevant to today s talk
Insulin therapy in type 2 diabetes When and how? Cecilia C Low Wang, MD Univ Colorado AMC SOM Department of Medicine Division of Endocrinology, Metabolism, and Diabetes Disclosures None relevant to today
More informationOral Therapy for Type 2 Diabetes
Oral Therapy for Type 2 Diabetes Diabetes pills can help to manage your blood sugar. These pills are not insulin. They work to manage your blood sugar in several ways. You may be given a combination of
More informationMedications for Diabetes
AGS Diab Med Brochure 4/18/03 3:43 PM Page 1 Medications for Diabetes An Older Adult s Guide to Safe Use of Diabetes Medications THE AGS FOUNDATION FOR HEALTH IN AGING AGS Diab Med Brochure 4/18/03 3:43
More informationVolume 01, No. 08 November 2013
State of New Jersey Department of Human Services Division of Medical Assistance & Health Services New Jersey Drug Utilization Review Board Volume 01, No. 08 November 2013 TO: SUBJECT: PURPOSE: Physicians,
More informationTransitions: MNT for Basic Diabetes Medications to Complex Insulin Regimens. Sara Weigel RDN, LD, CDE MAND Annual Meeting May 1 st 2015
Transitions: MNT for Basic Diabetes Medications to Complex Insulin Regimens Sara Weigel RDN, LD, CDE MAND Annual Meeting May 1 st 2015 Objectives 1) Describe and discuss some of the most common diabetes
More informationThere seem to be inconsistencies regarding diabetic management in
Society of Ambulatory Anesthesia (SAMBA) Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Review of the consensus statement and additional
More informationManagement of Clients with Diabetes Mellitus
Management of Clients with Diabetes Mellitus Black, J.M. & Hawks, J.H. (2005) Chapters 47, (pp 1243-1288) 1288) Baptist Health School of Nursing NSG 4037: Adult Nursing III Carole Mackey, MNSc,, RN, PNP
More informationINSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT?
INSULIN AND INCRETIN THERAPIES: WHAT COMBINATIONS ARE RIGHT FOR YOUR PATIENT? MARTHA M. BRINSKO, MSN, ANP-BC CHARLOTTE COMMUNITY HEALTH CLINIC CHARLOTTE, NC Diagnosed and undiagnosed diabetes in the United
More informationChapter 4 Type 2 Diabetes
Chapter 4 Type 2 Diabetes (previously referred to as adult onset diabetes or non-insulin dependent diabetes) H. Peter Chase, MD Cindy Cain, RN, CDE Philip Zeitler, MD This is the most common type of diabetes
More informationType 2 diabetes Definition
Type 2 diabetes Definition Type 2 diabetes is a lifelong (chronic) disease in which there are high levels of sugar (glucose) in the blood. Type 2 diabetes is the most common form of diabetes. Causes Diabetes
More informationE-mail: david.bruyette@vcahospitals.com www.veterinarydiagnosticinvestigation.com
David Bruyette, DVM, DACVIM VCA West Los Angeles Animal Hospital 1818 South Sepulveda Blvd Los Angeles, CA 90025 310-473-2951 (ext 226) E-mail: david.bruyette@vcahospitals.com www.veterinarydiagnosticinvestigation.com
More informationDiabetes: Beyond the D50. Leslie Huntington, BS, Paramedic Mobile Training Unit Oregon OHA-EMS and Trauma Systems
Diabetes: Beyond the D50 Leslie Huntington, BS, Paramedic Mobile Training Unit Oregon OHA-EMS and Trauma Systems The EMS View of Diabetes Management BG low? Give some form of sugar. Hero! BG somewhere
More information2013 International Diabetes Center
Day to Day Management of Diabetes Part 1 Review of Diabetes and Therapies Diane Reader RD, CDE Manager, Diabetes Professional Training International Diabetes Center Overview of Diabetes lucose and Insulin
More informationType 2 Diabetes. Aims and Objectives. What did you consider? Case Study One: Miss S. Which to choose?!?! Modes of Action
Aims and Objectives This session will outline the increasing complexities of diabetes care, and the factors that differentiate the combinations of therapy, allowing individualisation of diabetes treatment.
More informationDiabetes, Type 2. RelayClinical Patient Education Sample Topic Diabetes, Type 2. What is type 2 diabetes? How does it occur?
What is type 2 diabetes? Type 2 diabetes is a disorder that happens when your body does not make enough insulin or is unable to use its own insulin properly. The inability to use insulin is called insulin
More informationINSULINThere are. T y p e 1 T y p e 2. many different insulins for
T y p e 1 T y p e 2 INSULINThere are many different insulins for Characteristics The three characteristics of insulin are: Onset. The length of time before insulin reaches the bloodstream and begins lowering
More informationDiabetes DIABETES MELLITUS. Types of Diabetes. Classification of Diabetes 6. 10. 2013. Prediabetes: IFG, IGT, Increased A1C
Diabetes Diabetes mellitus is a chronic disease characterized by high levels of blood glucose resulting from defects in insulin production, insulin action, or both. A state of raised blood glucose (hyperglycaemia)
More informationUpdate on the management of Type 2 Diabetes
Update on the management of Type 2 Diabetes Mona Nasrallah M.D Assistant Professor, Endocrinology American University of Beirut 10 th Annual Family Medicine Conference October 14,2011 Global Prevalence
More informationMy Diabetes Care Plan
My Diabetes Care Plan You may use the charts below to help you better understand your diabetes. Ask your healthcare provider to review your goals and targets with you. Discuss the results and set up an
More informationEffective pharmacological treatment regimens for diabetes usually require
Medications Used in Diabetes in Patients Presenting for Anesthesia By Gabrielle O Connor, M.D., M.Sc., CCD, MRCP, FACP Dr. Gabrielle O Connor, a board certified endocrinologist who graduated from University
More informationInsulin and Other Glucose-Lowering Drugs
Insulin and Other Glucose-Lowering Drugs I. OVERVIEW The pancreas is both an endocrine gland that produces the peptide hormones insulin, glucagon, and somatostatin and an exocrine gland that produces digestive
More information6/22/2015. New medicines for type 2 diabetes when do you use them
New medicines for type 2 diabetes when do you use them 1. Oral Secretagogues (e.g. sulfonylureas) 2. Metformin 3. Alpha glucosidase inhibitors 4. Thiazolidinediones 5. GLP-1 receptor agonists 6. DPP-4
More informationClinical Assistant Professor. Clinical Pharmacy Specialist Wesley Family Medicine Residency Program. Objectives
What s New in Diabetes Medications? Matthew Kostoff, PharmD, BCPS, BCACP Clinical Assistant Professor Clinical Pharmacy Specialist Wesley Family Medicine Residency Program Objectives Discuss new literature
More informationHow To Help People With Diabetes
Diabetes Medications and Medication Management Christopher Lamer, PharmD, MHS, BCPS, CDE November 2013 Okay, great. Well, I want to say thank you very much for giving me the opportunity to present and
More informationHarmony Clinical Trial Medical Media Factsheet
Overview Harmony is the global Phase III clinical trial program for Tanzeum (albiglutide), a product developed by GSK for the treatment of type 2 diabetes. The comprehensive program comprised eight individual
More informationInsulin Initiation and Intensification
Insulin Initiation and Intensification ANDREW S. RHINEHART, MD, FACP, CDE MEDICAL DIRECTOR AND DIABETOLOGIST JOHNSTON MEMORIAL DIABETES CARE CENTER Objectives Understand the pharmacodynamics and pharmacokinetics
More informationIt is estimated that 25.8 million people or 8.3% of the US
1.0 CPEUs and 2.0 ANCC Contact Hours An Overview of Glycemic Goals and Medications Used to Manage Type 2 Diabetes Mary-Kathleen Grams, PharmD Suzanne Dinsmore, PharmD, CGP Jennifer Goldman-Levine, PharmD,
More informationDiabetes Medications: Insulin Therapy
Diabetes Medications: Insulin Therapy Courtesy Univ Texas San Antonio Eric L. Johnson, M.D. Department of Family and Community Medicine Diabetes and Insulin Type 1 Diabetes Autoimmune destruction of beta
More informationStaying Healthy With Diabetes
Staying Healthy With Diabetes For: We care. We will listen. We can help. Table of Contents Table of Contents... 1 Staying Healthy with Diabetes... 2 About Diabetes... 3 Blood Glucose Testing at Home...
More informationNewer Anticoagulants and Newer Diabetic Drug Classes. Nicole N. Nguyen, PharmD Senior Clinical Pharmacist Health Care Services August 21, 2013
Newer Anticoagulants and Newer Diabetic Drug Classes Nicole N. Nguyen, PharmD Senior Clinical Pharmacist Health Care Services August 21, 2013 Apixaban Newer Anticoagulants Dabigatran etexilate Rivaroxaban
More informationDiabetes Mellitus Type 2
Diabetes Mellitus Type 2 What is it? Diabetes is a common health problem in the U.S. and the world. In diabetes, the body does not use the food it digests well. It is hard for the body to use carbohydrates
More informationDiabetes may be classified as. i) Type - I Diabetes mellitus. Type - II Diabetes mellitus. Type - 1.5 Diabetes mellitus. Gestational Diabetes INSULIN
HYPOGLYCEMIC AGENT Diabetes mellitus is a chronic metabolic disorder of multiple aetiology characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting
More informationPANCREATIC HORMONES, ANTIDIABETIC AGENTS: INSULIN AND ORAL ANTIDIABETICS- handout Iwona Zaporowska-Stachowiak
PANCREATIC HORMONES, ANTIDIABETIC AGENTS: INSULIN AND ORAL ANTIDIABETICS- handout Iwona Zaporowska-Stachowiak The endocrine pancreas (the islets of Langerhans) consists of four types of endocrine cells:
More informationMANAGEMENT OF TYPE 2 DIABETES: REVIEW OF DRUG THERAPY
MANAGEMENT OF TYPE 2 DIABETES: REVIEW OF DRUG THERAPY AND THE ROLE OF THE PHARMACIST NINA BEMBEN, PHARMD MARY LYNN MCPHERSON, PAHRMD, MA, BCPS, CDE ZEMEN HABTEMARIAM, STUDENT PHARMACIST MANAGEMENT OF TYPE
More informationmedications for type 2 diabetes
Talking diabetes No.25 Revised 2012 medications for type 2 diabetes People with type 2 diabetes are often given medications including insulin to help manage their blood glucose levels. Most of these medications
More informationNew Non-Insulin Therapies for Type 2 Diabetes Mellitus
New Non-Insulin Therapies for Type 2 Diabetes Mellitus Ally P.H. Prebtani Associate Professor of Medicine Internal Medicine, Endocrinology & Metabolism McMaster University Canada Disclosure Relationships
More informationKaiser Sunnyside Medical Center Inpatient Pharmacy Manual
Page: 1 of 10 PURPOSE To provide a standard procedure for optimizing care of the inpatient with hyperglycemia and/or diabetes. Substantially provide safe and effective glucose control for all adult inpatients.
More informationTreating Type 2 Diabetes
The Oral Diabetes Drugs Treating Type 2 Diabetes Comparing Effectiveness, Safety, and Price Contents Our Recommendations........................................... 3 Welcome....................................................
More informationBASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS
BASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS C O N T A C T D I A B E T E S S E R V I C E S F O R M O R E I N F O R M A T I O N 8 4 7-9 1 7-6 9 0 7 THIS SLIDE PRESENTATION WAS PREPARED BY SUE DROGOS,
More informationINPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco CLINICAL RECOGNITION Background: Appropriate inpatient glycemic
More informationPharmacological Glycaemic Control in Type 2 Diabetes
Pharmacological Glycaemic Control in Type 2 Diabetes Aim(s) and Objective(s) This guideline aims to offer advice on the pharmacological management for those who require measures beyond diet and exercise
More informationDIABETES MEDICATION INSULIN
Section Three DIABETES MEDICATION INSULIN This section will tell you: About insulin. How to care and store your insulin. When to take your insulin. Different ways of taking insulin. WHAT IS INSULIN? Insulin
More informationmedications for type 2 diabetes
Talking diabetes No.25 Revised August 2010 medications for type 2 diabetes People with type 2 diabetes are often given medications including insulin to help control their blood glucose levels. Most of
More informationType 2 Diabetes in Children
Type 2 Diabetes in Children February 19, 2005 Brandon Nathan, MD Endocrinology Department of Pediatrics University of Minnesota Medical School University of Minnesota Masonic Children s Hospital Agenda
More informationNew and Standard Treatment Options for Patients With
New and Standard Treatment Options for Patients With Type 2 Diabetes Jointly sponsored by The Dulaney Foundation and DIABETIC MICROVASCULAR COMPLICATIONS TODAY. Release Date: October 2006. Expiration Date:
More informationUp to Date for Diabetes: Veronica Piziak MD, PhD Professor of Medicine Texas A&M Emeritus Director of Endocrinology Baylor Scott and White
Up to Date for Diabetes: Veronica Piziak MD, PhD Professor of Medicine Texas A&M Emeritus Director of Endocrinology Baylor Scott and White Objectives: What is New in Therapy How to select medications Disclosures:
More informationTypes of insulin and How to Use Them
Diabetes and Insulin Pumps Amy S. Pullen Pharm.D ISHP Spring Meeting April 2012 Objectives Describe the different types of insulin used in diabetes Identify the types of insulin that are compatible with
More informationTreating Type 2 Diabetes
The Oral Diabetes Drugs Treating Type 2 Diabetes Comparing Effectiveness, Safety, and Price Our Recommendations Six classes of oral medicines (and 12 individual drugs) are now available to help the 25.8
More informationInsulin Therapy. Endocrinologist. H. Delshad M.D. Research Institute For Endocrine Sciences
Insulin Therapy H. Delshad M.D Endocrinologist Research Institute For Endocrine Sciences Primary Objectives of Effective Management A1C % 9 8 Diagnosis SBP mm Hg LDL mg/dl 7 145 130 140 100 Reduction of
More informationMedication Review. What is Diabetes? Medications. Michelle Weddell. Business Development Executive Clinical Specialist Podiatrist
Medication Review Michelle Weddell Business Development Executive Clinical Specialist Podiatrist What is Diabetes? What is a type 1 diabetic? What is type 2 diabetic? Is there other forms of diabetes?
More information